Background {#Sec1}
==========

Expiratory flow limitation (EFL) is a dynamic condition in which expiratory flow has already reached its maximal value \[[@CR1]\]. According to Mead et al. \[[@CR2]\], once the expiratory flow is limited at a given lung volume, there is a site in the intrathoracic airways where intrabronchial and extrabronchial pressure are equal, the so-called equal pressure point (EPP) \[[@CR3]\]. Airways downstream of the EPP would be compressed, the diameter markedly reduced, with the expiratory flow becoming insensitive to increases of expiratory driving pressure or to the contraction of the expiratory muscles \[[@CR1], [@CR4]--[@CR7]\].

Clinically, EFL was demonstrated in patients with chronic obstructive pulmonary disease (COPD) \[[@CR4], [@CR8]\], acute respiratory distress syndrome (ARDS) \[[@CR9], [@CR10]\], acute and chronic heart failure \[[@CR11], [@CR12]\], cystic fibrosis \[[@CR13]\], spinal cord injury \[[@CR14]\] and obesity \[[@CR15]\]. Recently, EFL has been described in patients undergoing general anaesthesia for major abdominal surgery, and its presence was the best predictors of postoperative pulmonary complications \[[@CR16]\].

The mechanisms leading to EFL can vary among different pathologies. COPD patients may develop EFL because of increased expiratory resistance \[[@CR17]\] that tend to reduce the transmural pressure (i.e. the difference between the pressure inside and outside the airways), leading to the development of the EPP. Incomplete lung emptying is frequently associated with dynamic lung hyperinflation with the generation of intrinsic positive end-expiratory pressure (PEEPi) \[[@CR18]\]. The latter can have several adverse effects on haemodynamic (i.e. cardiac output depression, increased pulmonary vessel resistance), respiratory muscle function (i.e. altered length-tension characteristics of the diaphragm, increased work of breathing) and patient-ventilator interaction (i.e. patient-ventilator asynchrony). On the other hand, patients with ARDS \[[@CR19]\] or those undergoing general anaesthesia \[[@CR20]\] can experience a reduction of functional residual capacity (FRC) able both to increase the expiratory resistance and to favour the collapse of the small airways. The ensuing inspiration re-open those airways, and repetitive opening and closure of small airways has been shown to induce histological damage of small airways probably due to the development of high shear forces \[[@CR21], [@CR22]\]. This should elicit an inflammatory response and increase the risk of low lung volume injury \[[@CR23], [@CR24]\].

Although EFL seems to represent a relevant pathological condition, surprisingly, only few studies evaluated the prevalence of EFL in critically ill patients. Alvisi et al. \[[@CR8]\] demonstrated that almost every COPD patient (93%) is flow limited at intensive care unit (ICU) admission for an acute and chronic respiratory failure, while Koutsoukou et al. \[[@CR9]\] found that EFL might be common in patients with ARDS. However, both studies enrolled a small number of selected patients so that it is difficult to derive conclusions on the clinical relevance of EFL and its determinants.

The primary aim of the present study is to evaluate the prevalence of EFL in ICU patients requiring mechanical ventilation for acute respiratory failure, and to determine the main clinical characteristics and risk factors associated with the presence of EFL. Secondly, we explored the possible impact of the presence of EFL on patients' clinical outcome.

Methods {#Sec2}
=======

Design, setting and patients {#Sec3}
----------------------------

We performed a prospective, observational study conducted in the general ICU of the S. Anna University Hospital, Ferrara, Italy. The study was approved by the ethics committee of our institution (Azienda Ospedaliero-Universitaria Ferrara Ethic Committee, protocol number: 74/2016). Informed consent was obtained from each patient or next of kin. Patients were recruited over a 12-month period between April 2016 and April 2017.

We screened and included all consecutive patients admitted to the ICU older than 18 years with an acute respiratory failure and with an expected length of mechanical ventilation of 72 h or more, as judged by the physician in charge. Exclusion criteria were (1) pregnancy, (2) haemodynamic instability (i.e. heart rate ≥ 120 beats/min or cardiac arrhythmia; systolic blood pressure \< 90 or vasopressor use, i.e. dopamine or dobutamine ≥ 5 μg/kg/min or noradrenaline ≥ 0.1 μg/kg/min), (3) presence of laparostomy and (4) active air leakage (i.e. pneumothorax or presence of thoracic drainage) (Additional file [1](#MOESM1){ref-type="media"}).

The observational period started within 24 h from admission to ICU and continued for at least 72 h. Patients were followed for outcome assessment until hospital discharge.

Determination of EFL and respiratory variables {#Sec4}
----------------------------------------------

All measurements were performed by three investigators (FDC, CR, EM) equally expert in respiratory mechanics and data collection. Patients were studied in a semi-recumbent position, with a head of bed angle of 30°.

The presence of EFL was determined by the PEEP test. The latter is based on a sudden decrease of PEEP from 3 to 0 cmH~2~O at the end of inspiration in order to increase the expiratory driving pressure and establish whether or not the expiratory flow increases. If the expiratory flow increases after subtraction of PEEP, then the patient is classified as not flow limited. On the contrary, if the expiratory flow does not increase after subtraction of PEEP, the patient is classified as having EFL. This approach requires a specific manoeuvre to show two different flow-volume loops in the same display, and it is available on all modern ventilators. The flow-volume curve with 3 cmH~2~O of PEEP is used as a reference and fixed on the screen. The flow-volume curve of the ensuing breath in which PEEP is reduced to 0 cmH~2~O is superimposed to the previous one in order to determine if the two flow-volume curves overlap (i.e. the expiratory flow does not increase), or the flow-volume curve at ZEEP exhibit an increase of the expiratory flow (patient not flow limited) (Additional file [2](#MOESM2){ref-type="media"}). The accuracy and the reproducibility of the PEEP test have been compared to the Negative Expiratory Pressure (NEP) test and validated previously \[[@CR20]\]. Further, the same PEEP test was used to determine the value of PEEP able to eliminate the presence of EFL, the so-called PEEP-EFL. The latter was calculated as the minimal value of PEEP that, according to the flow-volume curve, allows the expiratory flow to increase during tidal expiration (Fig. [1](#Fig1){ref-type="fig"}). This was obtained by an incremental PEEP trial. Fig. 1Flow-volume curves of a representative patient aimed to determine the level of PEEP able to eliminate the presence of EFL (PEEP-EFL). **a** Until the subtraction of 4 cmH~2~O of PEEP the expiratory flow did not increased: the patient was considered flow limited at 4 cmH~2~O of PEEP. **b** Subtraction of 6 cmH~2~O of PEEP increased the expiratory flow. **c** Subtraction of 8 cmH~2~O increased the expiratory flow more than after the subtraction of 6 cmH~2~O of PEEP. The PEEP-EFL was 5 cmH~2~O. See text for further explanation

Respiratory mechanics were performed at zero-PEEP (ZEEP) by the standard airway occlusion technique using a 5-s end-expiratory occlusion followed by a 5-s end-inspiratory occlusion \[[@CR20]\]. The flow and additional resistance as well as the static compliance of the respiratory system were computed using standard formulas \[[@CR20]\]. During these tests, patients were deeply sedated using continuous intravenous infusion of propofol (1--2 mg/kg) and paralysed with a bolus of rocuronium bromide (0.6 mg/kg) and mechanically ventilated in volume-controlled mode. Patients with COPD were studied after at least 8 h from the administration of albuterol. As per our clinical practice, patients without COPD were not given bronchodilators.

The severity of chronic dyspnoea was rated according to the modified dyspnoea scale proposed by the Medical Research Council (mMRC) \[[@CR25]\].

Data collection and outcome data {#Sec5}
--------------------------------

The presence of EFL was determined at the ICU admission (within 12 h) and daily during the first 72 h. Data of respiratory mechanics were assessed at day 1 and at day 3 from ICU admission.

Demographics, anthropometrics, comorbidities, information and causes of hospitalisation were recorded into study-specific case report forms and database. COPD was defined according to recent ATS/ERS criteria \[[@CR26]\], and COPD severity was assessed by the Global Initiative for COPD (GOLD) criteria \[[@CR27]\]. Simplified Acute Physiology Score (SAPS) II and Sequential Organ Failure Assessment (SOFA) were determined during the first 24 h after ICU admission. The diagnosis of ARDS was based on the Berlin definition \[[@CR28]\]. The occurrences of acute kidney injury (AKI) and septic shock were diagnosed according to international guidelines statements, Kidney Disease: Improving Global Outcomes (KDIGO) criteria \[[@CR29]\] and surviving sepsis campaign (Sepsi-3) criteria \[[@CR30]\], respectively.

Daily fluid balance was recorded as the algebraic sum of fluid intake and output per day, not including insensible losses, while cumulative fluid balance (CFB) was calculated as the algebraic sum of daily fluid balance during the observational period. We reported CFB as absolute number or divided by the admission weight of the patient (CFB/kg). Cumulative fluid overload (CFO) was calculated by dividing the CFB by the admission weight of each patient and was expressed as a percentage, as previously proposed \[[@CR31]\]. We considered a CFO ≥ 10% as severe fluid overload.

Outcome data such as days of mechanical ventilation, ICU and hospital length of stay and ICU and hospital mortality were retrieved from the hospital's electronic patient chart.

Statistical analysis {#Sec6}
--------------------

Data are presented as frequencies and percentages and mean ± standard deviation or medians with 25th to 75th percentiles range \[interquartile range\], depending on the type of data and their distribution. The Shapiro-Wilk test was used to assess the assumption of normality. Categorical data were compared using the *χ*^2^ test or Fisher exact test as appropriate. Unpaired Student's *t* tests or Mann-Whitney *U* tests for data with normal or non-normal distribution, respectively, were used to compare continuous variables.

Friedman test was used to test differences in CFB, CFB/kg and CFO within groups among three different time points (24 h, 48 h and 72 h from ICU admission). Kruskal-Wallis test and Mann-Whitney test were used to test differences in CFB, CFB/kg and CFO between groups at three different time points (24 h, 48 h and 72 h from ICU admission). Correlation between CFB/kg and intrinsic PEEP was assessed by linear regression.

The association between the presence of EFL at admission and baseline patient characteristics was modelled using binary logistic regression analysis and reported as estimated odds ratio (OR) and relative 95% confidence interval (CI). Patients' characteristics independently associated with the presence of EFL at ICU admission were assessed in a multivariate logistic regression model. In the same fashion, a univariate logistic approach was used to assess the association between a CFO ≥ 10%, the development of AKI in ICU, AHRF, ARDS or septic shock at admission and the incidence of EFL during the first 72 h of ICU stay.

Statistical analyses were performed using SPSS 20.0 statistical software (SPSS Inc., Chicago, IL). In all statistical analyses, a 2-tailed test was performed and the *p* value ≤ .05 was considered statistically significant.

Results {#Sec7}
=======

A total of 121 patients were enrolled, and their main characteristics at admission are shown in Table [1](#Tab1){ref-type="table"}. The most frequent causes for ICU admission were acute hypoxaemic respiratory failure (AHRF) (43%), sepsis (37%), ARDS (24%) and haemorrhagic shock (9%). Among the 121 patients included, 28 had a diagnosis of COPD and 6 of them were admitted for an acute exacerbation of COPD. Table 1Clinical and demographic characteristics of the patients at ICU admissionVariablesTotal (*n* = 121)NO EFL (*n* = 84)EFL (*n* = 37)*p value*Age68 ± 1467 ± 1571 ± 120.181Male sex, *n* (%)81 (67)60 (71)21 (57)0.114BMI, kg/m^2^27.0 ± 5.625.3 ± 3.930.7 ± 6.8\< 0.0001SOFA at admission6 \[4--9\]6 \[4--8\]8 \[6--10\]0.015SAPSII42 \[31--48\]38 \[29--47\]42 \[35--53\]0.077Smoking history, *n* (%)0.343 Current smoker29 (24)17 (20)12 (32) Former smoker31 (26)16 (25)15 (26)mMRC *≥ 3*35 (29)9 (11)26 (70)\< 0.0001NYHA *≥ 2*62 (51)27 (32)35 (95)\< 0.0001Comorbidities, *n* (%) Heart diseases68 (56)40 (48)28 (76)0.004 Hypertension42 (35)28 (33)14 (38)0.632 Chronic cardiac ischaemia43 (36)22 (26)21 (57)0.001 COPD28 (23)9 (11)19 (51)\< 0.0001 OSAS7 (6)3 (4)4 (11)0.116 CKD21 (17)10 (12)11 (30)0.017Reason for MV initiation, *n* (%) AHRF52 (43)31 (37)21 (57)0.042 Sepsis45 (37)34 (41)11 (30)0.260 Septic shock28 (23)21 (25)7 (19)0.465 Haemorrhagic shock11 (9)8 (10)3 (8)0.803 Coma13 (11)11 (13)2 (5)0.208ARDS29 (24)13 (16)16 (43)0.001 Mild7 (24)3 (23)4 (24) Moderate14 (48)8 (62)6 (38) Severe8 (28)2 (15)6 (38)*EFL* expiratory flow limitation, *BMI* body mass index, *SOFA* Sequential Organ Failure Assessment, *SAPS II* Simplified Acute Physiology Score, *mMRC* modified Medical Research Council dyspnoea scale, *NYHA* New York Heart Association classification, *COPD* chronic obstructive pulmonary disease, *OSAS* obstructive sleep apnoea syndrome, *CKD* chronic kidney disease, *ICU* intensive care unit, *AHRF* acute hypoxaemic respiratory failure, *ARDS* acute respiratory distress syndrome

Occurrence of EFL {#Sec8}
-----------------

Upon admission, 37/121 (31%) patients exhibited EFL, with a median PEEP-EFL of 8 cmH~2~O \[[@CR6]--[@CR10]\]. Among the patients having EFL at admission, 19/37 (51%) had a diagnosis of COPD. Compared to those without EFL, flow-limited patients had a higher body mass index (BMI) (30.7 ± 6.8 vs 25.3 ± 3.9, *p* \< 0.0001) and worse respiratory dyspnoea score \[mMRC ≥ 3 26/37 (70%) vs 9/84 (11%), *p* \< 0.0001\]. EFL was more frequently associated with history of heart disease (28/37 (76%) vs 40/84 (48%), *p* = 0.004), COPD (19/37 (51%) vs 9/84 (11%), *p* \< 0.0001) and chronic kidney disease (11/37 (30%) vs 10/84 (12%), *p* = 0.017). Furthermore, the main factors independently related to EFL at ICU admission were a BMI ≥ 30 kg/m^2^ (OR 3.6, 95% CI 1.0--12.6, *p* = 0.049), a mMRC score ≥ 3 (OR 8.0, 95% CI 2.3--27.1, *p* = 0.001), a SOFA score ≥ 6 (OR 3.6, 95% CI 1.1--12.0, *p* = 0.036) and a medical history of COPD (OR 4.7, 95% CI 1.5--14.4, *p* = 0.008) (Table [2](#Tab2){ref-type="table"}). Table 2Association between baseline characteristics of patients and the presence of EFL at ICU admission according to logistic regression analysis adjusted for potential confoundersVariablesUnivariate analysisMultivariate analysisCrude odds ratio95% CI*p* valueAdjusted odds ratio95% CI*p* valueBMI *(ref: \< 30 kg/m*^*2*^*)* ≥ 30 kg/m^2^7.02.8--17.3\< 0.00013.61.0--12.60.049mMRC *(ref: \< 3)* ≥ 319.77.3--52.8\< 0.00018.02.3--27.10.001COPD *(ref: absence)* Presence8.83.4--22.6\< 0.00014.61.4--15.30.008Heart disease *(ref: absence)* Presence3.71.6--8.30.0021.60.5--5.00.418CKD *(ref: absence)* Presence3.11.2--8.20.0211.70.4--6.70.470SOFA score *(ref: \< 7)* ≥ 63.01.2--7.30.0163.61.1--12.00.036OSAS *(ref: absence)* Presence3.30.7--15.40.134Age *(ref: \< 70)* ≥ 700.90.5--2.10.968Smoking history *(ref: non-smoker)* Actual smoker1.80.7--4.60.203 Past smoker0.90.3--2.40.834SAPS II *(ref: \< 41)* ≥ 421.70.7--3.70.188*BMI* body mass index, *mMRC* modified Medical Research Council scale for dyspnoea, *COPD* chronic obstructive pulmonary disease, *CKD* chronic kidney disease, *OSAS* obstructive sleep apnoea syndrome, *SOFA* Sequential Organ Failure Assessment, *SAPS* Simplified Acute Physiology Score

During the first 72 h of ICU stay, 21 additional patients (17%) developed EFL. Specifically, 13 patients (11%) became flow limited after 48 h and 8 (7%) after 72 h. Their clinical characteristics are reported in Additional file [2](#MOESM2){ref-type="media"}. Of note, they exhibited a BMI similar to the one of patients without EFL and the diagnosis of COPD (Additional file [3](#MOESM3){ref-type="media"}). Finally, patients becoming flow limited during the ICU stay exhibited values of PEEP-EFL statistically lower than those with EFL at ICU admission (Additional file [4](#MOESM4){ref-type="media"}).

Data of respiratory mechanics {#Sec9}
-----------------------------

At the ICU admission, patients with EFL exhibited higher PEEPi (7 \[4--10\] vs 2 \[1--2\] cmH~2~O, *p* \< 0.0001), total airways resistance (22 \[17--26\] vs 16 \[13--21\] cmH~2~O/l/s *p* \< 0.0001) and additional resistance (10 \[6--14\] vs 7 \[5--10\] cmH~2~O/l/s, *p* = 0.001) (Table [3](#Tab3){ref-type="table"}). These differences remained constant during the ICU stay, being detected also at 72 h after ICU admission (Table [3](#Tab3){ref-type="table"}). Of note, data of respiratory mechanics of patients developing EFL during the ICU stay were not different from those obtained in the absence of EFL (Additional file [5](#MOESM5){ref-type="media"}). Table 3Data of respiratory mechanics at day 1 and day 3 after ICU admissionVariablesDay 1Day 3NO EFL (*n* = 84)EFL (*n* = 37)*p* valueNO EFL (*n* = 63)EFL (*n* = 58)*p* valueCst,rs, ml/cmH~2~O49 \[40--64\]47 \[38--56\]0.30948 \[39--61\]52 \[39--56\]0.652Rrs,max, cmH~2~O/l/s16 \[13--21\]22 \[17--26\]\< 0.000117 \[15--20\]21 \[17--27\]0.031Rrs,min, cmH~2~O/l/s8 \[6--12\]9 \[7--13\]0.2699 \[7--13\]9 \[7--14\]0.825ΔRrs, cmH~2~O/l/s7 \[5--10\]10 \[6--14\]0.0017 \[5--10\]11 \[6--14\]0.008P/F ratio257 \[177--370\]168 \[123--260\]0.003230 \[170--329\]183 \[134--265\]\< 0.0001PEEP~i~, cmH~2~O2 \[1--2\]7 \[4--10\]\< 0.00011 \[0--2\]6 \[4--9\]\< 0.0001PEEPappl, cmH~2~O7 \[6--8\]10 \[8--12\]\< 0.00018 \[6--10\]10 \[8--12\]\< 0.0001RR, breaths/min15 \[14--18\]15 \[14--16\]0.83915 \[14--17\]16 \[15--20\]0.065V~T~, ml/kg IBW7.3 \[6.7--7.3\]8.0 \[7.0--8.9\]0.0987.2 \[6.4--8.0\]7.3 \[6.1--7.9\]0.673Ppeak, cmH~2~O20 \[17--24\]27 \[24--31\]\< 0.000121 \[17--25\]29 \[22--33\]\< 0.0001Pplat, cmH~2~O17 \[15--19\]19 \[16--18\]0.00917 \[15--20\]19 \[15--21\]0.227Δ*P*, cmH~2~O9 \[8--12\]11 \[8--13\]0.2689 \[8--12\]9 \[7--12\]0.741*EFL* expiratory flow limitation, *Cst,rs* static compliance of the respiratory system, *Rrs,max* total resistance of the respiratory system, *Rrs,min* flow resistance of the respiratory system, *ΔRrs* additional resistance of the respiratory system, *P/F* arterial partial oxygen pressure to fraction of inspired oxygen ratio, *PEEPi* intrinsic positive end-expiratory pressure, *PEEP appl* positive end-expiratory pressure applied at the ventilator, *RR* respiratory rate, *V*~*T*~ tidal volume, *IBW* ideal body weight, *Ppeak* peak inspiratory pressure, *Pplat* plateau pressure, ***Δ****P* driving pressure

Cumulative fluid balance and EFL development {#Sec10}
--------------------------------------------

Patients who developed EFL during the first 72 h of ICU stay had a higher cumulative fluid balance and cumulative fluid overload compared to patients without EFL and with EFL at ICU admission. The trend of cumulative fluid accumulation is shown in Fig. [2](#Fig2){ref-type="fig"} and in Additional file [6](#MOESM6){ref-type="media"}. Fig. 2Cumulative fluid balance over the first 3 days of ICU stay. Patients who developed expiratory flow limitation (EFL) after ICU admission (blue) had higher cumulative fluid balances compared to those flow limited at admission (violet), and those who never developed EFL (red)

In patients developing EFL during the ICU stay, a higher cumulative fluid balance was associated with higher values of intrinsic PEEP on the day of EFL development (*R*^2^ = 0.304, *p* = 0.010) (Fig. [3](#Fig3){ref-type="fig"}). Fig. 3Correlation between CFB and values of PEEPi in patients developing EFL after the ICU admission. The correlation was determined the day the patients became flow limited

Moreover, a CFO ≥ 10% over the first 2 and 3 days of ICU stay was associated with the development of EFL over the first 3 days of stay in ICU (OR 3.9, 95% CI 1.4--10.9, *p* = 0.011 and OR 3.1 95% CI 1.1--8.5, *p* = 0.030, respectively) (Table [4](#Tab4){ref-type="table"}). Table 4Association between severe cumulative fluid overload and development of expiratory flow limitation according to univariate logistic regression analysisVariablesCrude odds ratio95%CI*p* valueCFO ≥ 10% 1st to 2nd ICU day of stay3.91.4--10.90.011CFO ≥ 10% 1st to 3rd ICU day of stay3.11.1--8.50.030AKI in ICU2.20.8--6.00.796AHRF0.20.1--1.20.075ARDS0.90.2--3.60.862Septic shock2.50.9--6.80.077*CFO* cumulative fluid overload, *AKI* acute kidney injury, *ICU* intensive care unit, *AHRF* acute hypoxaemic respiratory failure, *ARDS* acute respiratory distress syndrome

Outcomes {#Sec11}
--------

Overall, patients who had EFL at admission and developed EFL over the first 72 h of ICU stay were ventilated for a longer time (9 \[5--15\] vs 7 \[3--14\] days, *p* = 0.043) and had a longer ICU length of stay (14 \[10--19\] vs 10 \[6--17\] days, *p* = 0.034) and higher ICU mortality (17/58 (29%) vs 9/63 (14%), *p* = 0.044) compared to those without EFL.

Patients who developed EFL during the first 3 days of ICU stay were not ventilated for a longer time (8 \[3--15\] vs 7 \[3--14\] days, *p* = 0.448) and had no longer ICU length of stay (14 \[8--18\] vs 10 \[6--17\] days, *p* = 0.344) and higher ICU mortality (5/21 (24%) vs 9/63 (14%), *p* = 0.310) compared to patients who never developed EFL.

Discussion {#Sec12}
==========

The main results of the present study can be summarised as follows: (1) EFL is frequent among ICU patients requiring mechanical ventilation for acute respiratory failure of different origin; (2) patients exhibiting EFL have worse parameters of respiratory mechanics and clinical outcome compared to those who did not; (3) the absence of EFL at ICU admission does not exclude its occurrence during ICU stay since part of the patients (17%) developed EFL after ICU admission; and (4) the development of EFL during the ICU stay was strongly associated with a positive fluid balance.

The presence of EFL was previously detected in 93% of the COPD patients at ICU admission \[[@CR8]\], and their pathophysiological pulmonary characteristics explain why they are prone to develop EFL compared to other categories of patients. However, the presence of EFL has been previously demonstrated in other patients so that it could be hypothesised that an unknown amount of ICU patients other than COPD can exhibit EFL. This could have relevant clinical consequences since the presence of EFL has numerous side effects \[[@CR1]\], such as the presence of PEEPi \[[@CR32]\] that might have detrimental effects on respiratory efficiency and cardiovascular function. Further, the reduction of the expiratory flow and the inability to increase it by the expiratory muscle contraction decrease the efficacy of cough and secretion removal \[[@CR14]\] favouring the development of atelectasis, bronchitis and pneumonia. Finally, EFL might imply cyclic opening/closure of the small airways \[[@CR7], [@CR33]\] that can lead to hypoxaemia and ventilation/perfusion mismatch.

Interestingly, a large amount of the patients enrolled in the present study (48%) were flow limited within the first 72 h of ICU stay, suggesting that EFL is common in ICU patients. Patients with EFL had higher duration of mechanical ventilation, ICU length of stay and ICU mortality. These outcomes were associated with a more compromised respiratory function since these patients exhibited increased inspiratory and additional resistance and higher PEEPi.

However, our study shows another complementary aspect that deserves clinical attention. We were surprised that 21 patients (17%) became flow limited after ICU admission. While it is easily explainable that obese patients or those with COPD or heart disease can exhibit EFL at ICU admission, it could be less clear why patients might develop EFL during the ICU stay. Interestingly, the main determinant of EFL after ICU admission was a positive fluid balance. Patients who developed EFL during the first 72 h of ICU stay had the higher cumulative fluid overload (Table [4](#Tab4){ref-type="table"} and Fig. [2](#Fig2){ref-type="fig"}); further, a CFO ≥ 10% over the first 2 days of ICU stay was independently associated with EFL (OR 3.7, 95%CI 1.2--11.4, *p* = 0.025).

Hence, fluid therapy can have relevant clinical consequences even at the lung level. Physician should pay particular attention to the amount of fluid administered. Excessive fluids administration can lead to EFL. The latter has been demonstrated to be responsible of damage of small airways that elicit an inflammatory response \[[@CR22], [@CR23]\]. It was previously demonstrated that a positive fluid balance can worsen respiratory function, increase the occurrence of pulmonary complication and have an impact on patients' outcome in patients with acute lung injury and ARDS \[[@CR34]--[@CR36]\].

Detecting and abolishing EFL should be part of the lung-protective strategy. Ventilation at low lung volume leading to EFL could be avoided by the use of PEEP. In patients with flow limited at the ICU admission, the value of PEEP able to avoid EFL was 8 \[6--10\] cmH~2~O and then statistically decreased to 6 \[5--8\] at day 3, while in those developing EFL during the ICU stay, this value was 5 \[5--6\] cmH~2~O at day 1 and 5 \[4--7\] at day 3. The effects of PEEP on EFL have been previously tested in patients with ARDS. Koutsoukou et al. \[[@CR37]\] demonstrated that 10 cmH~2~O of PEEP abolished the presence of EFL during tidal ventilation. The difference between the two studies could be the patients' population, the severity of the underlying disease and the number of patients enrolled. Koutsoukou et al. \[[@CR37]\] studied 13 patients while we enrolled 121 patients with ARF of different aetiologies.

The present study has some limitations: (1) it is a single-centre design with limited sample size. However, this is the first study aiming at identifying possible causes of EFL occurrence in an unselected cohort of ventilated patients; (2) we did not use other techniques such as extra-vascular lung water measurement or lung ultrasound to quantify lung oedema for confirming the association between cumulative fluid overload and EFL occurrence; (3) application of the PEEP test, as it is for all tests evaluating the presence of EFL, carries the need of having the patients for one breath at ZEEP. This could partially derecruit the lung, although the limited time on ZEEP ventilation should minimise the possible effects of the PEEP test on lung function; and (4) we have reported some data on the association between EFL prevalence/development and ICU mortality. However, these data should be regarded only as descriptive since the observational nature of this study and the small sample size do not allow us to make any conclusion. Future larger studies are needed to prove the potential effect of EFL development on the increase of ICU mortality.

Conclusions {#Sec13}
===========

The presence of EFL is common among ICU patients requiring mechanical ventilation for acute respiratory failure of different aetiologies. Interestingly, the major determinant for developing EFL in patients during the first 3 days of their ICU stay is a positive fluid balance. Further studies are needed to assess if a restrictive fluid therapy might be associated with a lower incidence of EFL.

Supplementary information
=========================

 {#Sec14}

**Additional file 1.** Flow chart of the study **Additional file 2.** Flow-volume loops during positive end-expiratory pressure (PEEP) test **Additional file 3.** Clinical and Demographic Characteristics of the Patients Enrolled grouped according to the absence / presence of EFL **Additional file 4.** "PEEP-EFL" values calculated according to the PEEP test in patients with EFL. **Additional file 5.** Respiratory mechanics characteristic of the patients who developed EFL during the ICU stay. **Additional file 6.** Cumulative fluid balance and cumulative fluid overload over the first 3 days of ICU stay.

AHRF

:   Acute hypoxaemic respiratory failure

AKI

:   Acute kidney injury

ARDS

:   Acute respiratory distress syndrome

BMI

:   Body mass index

CFB

:   Cumulative fluid balance

CFO

:   Cumulative fluid overload

CKD

:   Chronic kidney disease

CI

:   Confidence interval

COPD

:   Chronic obstructive pulmonary disease

Cst,rs

:   Static compliance of the respiratory system

ΔP

:   Driving pressure

ΔRrs

:   Additional resistance of the respiratory system

EFL

:   Expiratory flow limitation

EPP

:   Equal pressure point

KDIGO

:   Kidney Disease Improving Global Outcomes

IBW

:   Ideal body weight

ICU

:   Intensive care unit

MRC

:   Modified Medical Research Council

NYHA

:   New York Heart Association classification

OR

:   Odds ratio

OSAS

:   Obstructive sleep apnoea syndrome

PEEP

:   Positive end-expiratory pressure

PEEPappl

:   Positive end-expiratory pressure applied at the ventilator

PEEPi

:   Intrinsic positive end-expiratory-pressure

P/F

:   Arterial partial oxygen pressure to fraction of inspired oxygen ratio

Ppeak

:   Peak inspiratory pressure

Pplat

:   Plateau pressure

RR

:   Respiratory rate

Rrs,max

:   Total resistance of the respiratory system

Rrs,min

:   Flow resistance of the respiratory system

SAPS

:   Simplified Acute Physiology Score

SOFA

:   Sequential Organ Failure Assessment

V~T~

:   Tidal volume

ZEEP

:   Zero-PEEP
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